Nuveen’s Lineage Cell Therapeutics LCTX Stock Holding History

Nuveen’s Portfolio LCTX Stock Details LCTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-515,445	Closed	-$233K	–	3338
2025 Q1	$233K	Hold	515,445	–	–	﹤0.01%	3094
2024 Q4	$259K	Hold	515,445	–	–	﹤0.01%	3157
2024 Q3	$467K	Hold	515,445	–	–	﹤0.01%	3038
2024 Q2	$514K	Hold	515,445	–	–	﹤0.01%	2983
2024 Q1	$763K	Hold	515,445	–	–	﹤0.01%	2810
2023 Q4	$562K	Hold	515,445	–	–	﹤0.01%	2968
2023 Q3	$608K	Hold	515,445	–	–	﹤0.01%	2778
2023 Q2	$727K	Buy	+515,445	New	+$712K	﹤0.01%	2798
2022 Q2	–	Sell	-551,993	Closed	-$750K	–	3383
2022 Q1	$750K	Buy	551,993 +145,063	+36%	+$225K	﹤0.01%	2906
2021 Q4	$745K	Sell	406,930 -34,661	-8%	-$81.1K	﹤0.01%	2955
2021 Q3	$1.13M	Sell	441,591 -8,320	-2%	-$21.3K	﹤0.01%	2952
2021 Q2	$1.28M	Buy	+449,911	New	+$1.16M	﹤0.01%	2913
2020 Q2	–	Sell	-423,265	Closed	-$350K	–	3321
2020 Q1	$350K	Sell	423,265 -66,546	-14%	-$66.3K	﹤0.01%	2895
2019 Q4	$435K	Sell	489,811 -580,940	-54%	-$484K	﹤0.01%	2936
2019 Q3	$1.05M	Buy	1,070,751 +72,602	+7%	+$75.2K	﹤0.01%	2686
2019 Q2	$1.1M	Buy	+998,149	New	+$1.15M	﹤0.01%	2698

Other funds holding LCTX

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return